Plant Oil Shows Promise in Lab Study of Type 1 Diabetes—What We Know So Far

Research in rats suggests that L. sativum oil may help preserve pancreatic function and improve blood sugar control in type 1 diabetes. The findings are preliminary and limited to animal models.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

In rats with streptozotocin-induced type 1 diabetes, L. sativum oil treatment lowered blood glucose levels and improved insulin production compared to untreated diabetic rats.
Pancreatic tissue from treated rats showed better preservation of islet structure and less damage than tissue from untreated diabetic rats.
This is early-stage laboratory research in animals—human studies would be needed to determine if these effects apply to people with type 1 diabetes.
L. sativum (garden cress) contains compounds like flavonoids and phenolic acids that have been used traditionally to support blood sugar management.

A Traditional Plant, Tested in the Lab

Garden cress, known scientifically as L. sativum, has been used in traditional medicine for centuries to help manage blood sugar. The plant is rich in compounds called phytochemicals—including flavonoids, phenolic acids, and glucosinolates—that may have protective effects on metabolism.

To explore whether L. sativum oil might help in type 1 diabetes, researchers recently conducted a controlled study in rats. The goal was to see if the oil could preserve pancreatic function and improve metabolic markers in animals with diabetes induced by streptozotocin, a chemical that damages insulin-producing cells.

What the Study Found

Researchers divided 48 young male rats into four groups: a healthy control group, a diabetic group without treatment, a diabetic group treated with L. sativum oil, and a healthy group that received the oil alone.

Compared to untreated diabetic rats, those given L. sativum oil showed meaningful improvements: blood glucose fell to 146.33 mg/dL (from much higher levels in untreated diabetic rats), insulin levels rose to 15.51 µIU/mL, and lipid profiles improved.

When researchers examined pancreatic tissue under a microscope, untreated diabetic rats showed severe damage—shrinkage of insulin-producing islets, cell damage, and scarring. In contrast, rats treated with L. sativum oil showed better preservation of islet structure and less overall tissue damage.

Important Limitations and Next Steps

This research is a proof-of-concept study in laboratory animals. Results in rats do not automatically translate to humans. Type 1 diabetes in humans is a complex autoimmune condition, and the rat model used here was chemically induced, not autoimmune.

Before L. sativum oil could be considered for human use, multiple steps would be needed: further animal studies, safety and toxicity testing, and clinical trials in people with type 1 diabetes.

If you are interested in complementary approaches to blood sugar management, it is important to discuss any dietary supplements or herbal remedies with your healthcare team, who can advise based on your individual situation.

Evidence label

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.